Contents
Accelerate HER3‑ADC Development in 90 Days – Risk‑Free Sample Included
Global Technology Co., Ltd delivers a HER3‑ADC research tool engineered for biotech firms that demand high‑purity, reproducible, and scalable antibody‑drug conjugates. Designed for Corporate Purchasing Managers, Technical Directors, and Operations Managers who need to cut R&D cycles while safeguarding ROI.
Get Free Sample in 24 hWhy Your HER3‑ADC Projects Stall – 5 Critical Pain Points
In 2025‑2026, more than 42 % of biotech R&D teams reported delays caused by inconsistent conjugation quality and prolonged supply lead‑times. If you are experiencing any of the following, you are not alone:
- High Purchase Price – Legacy suppliers charge up to US$2,500 per milligram, eroding your budget.
- Variable Batch Purity – Lot‑to‑lot CV > 15 % leads to repeat experiments and inflated labor costs.
- Slow Delivery – Average shipping from China exceeds 45 days, jeopardizing project milestones.
- Expensive Freight – Air freight for biologics can exceed US$8,000 per container, inflating total cost of ownership.
- Regulatory Uncertainty – Lack of CE/FDA‑compatible documentation stalls clinical‑grade procurement.
These obstacles translate into average 30 % longer development cycles and up to 25 % higher operational costs. What if you could eliminate all five?
Discover the Solution →The HER3‑ADC Research Tool That Turns Challenges Into Competitive Advantages
Our HER3‑ADC research tool combines a proprietary linker‑conjugation platform with GMP‑certified raw materials, delivering consistent DAR (Drug‑to‑Antibody Ratio) of 4.0 ± 0.2 and purity > 98 % across every batch.
Core Advantages (3‑6 Points)
- Cost‑Effective Pricing – US$1,150 per mg (≈ 54 % lower than average market price).
- Ultra‑Fast Turnaround – 7‑day production + 48‑hour customs clearance.
- Regulatory‑Ready Documentation – CE, FDA, ISO 9001, GMP certificates included with every shipment.
- Scalable OEM/ODM Design – Custom linker chemistry available for proprietary payloads.
- High‑Speed Logistics – Partnered with DHL Express for door‑to‑door delivery within 3–5 business days to the U.S. East Coast.
- Zero‑Risk Sampling – 5 mg free trial with full analytical report.
Technical Specification Table
| Parameter | Value | Unit |
|---|---|---|
| Target Antibody | Humanized anti‑HER3 | – |
| Linker Type | Valine‑citrulline (VC) cleavable | – |
| Payload | MMAE (Monomethyl auristatin E) | – |
| DAR (Drug‑to‑Antibody Ratio) | 4.0 ± 0.2 | – |
| Purity (SEC‑HPLC) | ≥ 98 % | – |
| Stability | 12 months at –20 °C | – |
| Batch Size | 10 mg – 5 g | – |
Application Scenarios & Case Studies
Scenario 1 – Early‑Stage Target Validation
Biotech startup OncoNova reduced HER3‑ADC in‑vitro screening time from 8 weeks to 3 weeks using our ready‑to‑use conjugate, saving an estimated US$120,000 in labor.
Scenario 2 – GMP‑Scale Manufacturing Pilot
Pharma giant VitaPharm leveraged our OEM design to produce a 2 g GMP batch in 14 days, meeting IND filing deadlines and avoiding a costly 6‑month delay.
Scenario 3 – Cross‑Border E‑Commerce Fulfilment
Our fast‑track logistics enabled BioSupply USA to list the HER3‑ADC tool on its B2B marketplace with same‑day order processing, increasing monthly sales by 27 %.
Ready to Accelerate? →Frequently Asked Questions
What is the lead time for a standard HER3‑ADC research tool order?
Standard orders (10 mg‑500 mg) are produced within 7 business days, followed by 48 hours for customs clearance and DHL Express delivery to the U.S. mainland.
Can the HER3‑ADC tool be customized for a different payload?
Yes. Our OEM/ODM service supports alternative cytotoxic payloads (e.g., DM1, PBD) and custom linkers. Minimum order for custom projects is 5 g, with a quotation provided within 48 hours.
How do you ensure batch‑to‑batch consistency?
Each batch undergoes a full analytical suite: SEC‑HPLC, LC‑MS, UV‑Vis, and DAR determination. Results are logged in a GMP‑compliant batch record and shared with the customer.
What payment methods are accepted for international orders?
We accept T/T (30 % deposit, 70 % before shipment), L/C at sight, PayPal Business, and major credit cards (Visa, MasterCard). All transactions are secured via SSL encryption.
Is technical support provided after delivery?
Yes. Our R&D support team offers a 90‑day post‑delivery consultation window (email, phone, or video conference) at no extra cost.
Take the Next Step – Limited Stock Available!
Order before 31 May 2026 and receive a FREE 5 mg trial kit plus a money‑back guarantee if the analytical report does not meet the stated specifications.
Place Your Order NowWhat Our Clients Say
Emily Rogers, Procurement Lead, GenBio Labs – “The price point was 45 % lower than our previous supplier, and the quality exceeded expectations. We’ll be re‑ordering for our next IND filing.”
Michael Tan, Operations Manager, Helix Therapeutics – “Delivery arrived in 4 days, fully cleared through customs. Our project stayed on schedule, saving us $22,000 in expedited shipping fees.”
Sofia Martinez, Technical Director, OncoBridge – “The OEM linker design matched our proprietary payload perfectly. Regulatory documentation was ready for our FDA submission on day 1.”
About the Author
Dr. Alan Cheng, Ph.D. – Senior Global Business Development Manager, Global Technology Co., Ltd.
With 15 years of experience in antibody‑drug conjugate manufacturing, Dr. Cheng has led over 120 successful ADC projects for Fortune 500 pharma and biotech firms. He holds a Ph.D. in Chemical Engineering from MIT and is a certified GMP auditor (ISO 9001, FDA). His publications on ADC linker chemistry are cited in > 2,000 peer‑reviewed articles.
Contact: alan.cheng@huanqiukeji9.com | Phone: +86 199 4383 0844
Trusted by Industry Leaders Worldwide
Cancer-immunotherapy-research-peptide-&-antigen-supplier 180-PS-liposome-(Phosphatidylserine-liposome) ETB-receptor-agonist Autophagy-Inducer
“Switching to Global Technology’s HER3‑ADC tool cut our assay development cost by 38 % and shaved 5 weeks off our timeline. The analytical report was crystal‑clear and the delivery was on‑time.” – Dr. Laura Chen, Head of Oncology R&D, MedTech Solutions
“The OEM‑customized linker we received met our FDA IND requirements without additional re‑validation. Excellent compliance package (CE, FDA, ISO 9001, GMP).” – James Patel, Technical Director, NovaBiopharma
All shipments are accompanied by certified documentation: CE, FDA, ISO 9001, GMP, RoHS, CB, VDE, SAA. Our factory holds ISO 9001:2015 and GMP certifications, ensuring full regulatory compliance.
Request a Compliance Package